French investigators reported the addition of temozolomide to vincristine and irinotecan may improve outcomes of children and adults with relapsed or refractory rhabdomyosarcoma, based on the results of a randomized Phase II study recently presented at ASCO reports...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
